SOAT1 and neoplasm: In contrast, given the pro-tumorigenic role for IL-6 in vivo and decades of work establishing its ability to promote tumor cell survival, invasion, and metastasis, there has been great interest in the therapeutic targeting of IL-6/JAK/STAT signaling [127].